These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 15897573)
1. Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Kumarakulasingham M; Rooney PH; Dundas SR; Telfer C; Melvin WT; Curran S; Murray GI Clin Cancer Res; 2005 May; 11(10):3758-65. PubMed ID: 15897573 [TBL] [Abstract][Full Text] [Related]
2. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Downie D; McFadyen MC; Rooney PH; Cruickshank ME; Parkin DE; Miller ID; Telfer C; Melvin WT; Murray GI Clin Cancer Res; 2005 Oct; 11(20):7369-75. PubMed ID: 16243809 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of TROP2 expression in colorectal cancer. Ohmachi T; Tanaka F; Mimori K; Inoue H; Yanaga K; Mori M Clin Cancer Res; 2006 May; 12(10):3057-63. PubMed ID: 16707602 [TBL] [Abstract][Full Text] [Related]
4. Profiling markers of prognosis in colorectal cancer. Lyall MS; Dundas SR; Curran S; Murray GI Clin Cancer Res; 2006 Feb; 12(4):1184-91. PubMed ID: 16489072 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371 [TBL] [Abstract][Full Text] [Related]
6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805 [TBL] [Abstract][Full Text] [Related]
7. RNA expression of cytochrome P450 in breast cancer patients. Vaclavikova R; Hubackova M; Stribrna-Sarmanova J; Kodet R; Mrhalova M; Novotny J; Gut I; Soucek P Anticancer Res; 2007; 27(6C):4443-50. PubMed ID: 18214058 [TBL] [Abstract][Full Text] [Related]
8. Profiling the expression of cytochrome P450 in breast cancer. Murray GI; Patimalla S; Stewart KN; Miller ID; Heys SD Histopathology; 2010 Aug; 57(2):202-11. PubMed ID: 20716162 [TBL] [Abstract][Full Text] [Related]
9. Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray. Watanabe T; Kobunai T; Tanaka T; Ishihara S; Matsuda K; Nagawa H Dis Colon Rectum; 2009 Dec; 52(12):1941-8. PubMed ID: 19934913 [TBL] [Abstract][Full Text] [Related]
10. Fatty acid binding protein 6 is overexpressed in colorectal cancer. Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225 [TBL] [Abstract][Full Text] [Related]
12. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance. Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410 [TBL] [Abstract][Full Text] [Related]
13. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
14. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Xi Y; Formentini A; Nakajima G; Kornmann M; Ju J Oncol Rep; 2008 Jan; 19(1):257-62. PubMed ID: 18097604 [TBL] [Abstract][Full Text] [Related]
15. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264 [TBL] [Abstract][Full Text] [Related]
16. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798 [TBL] [Abstract][Full Text] [Related]
17. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Yamasaki M; Takemasa I; Komori T; Watanabe S; Sekimoto M; Doki Y; Matsubara K; Monden M Int J Oncol; 2007 Jan; 30(1):129-38. PubMed ID: 17143521 [TBL] [Abstract][Full Text] [Related]
18. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study. Gulubova M; Vlaykova T J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of BMP7 in human colorectal cancer. Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822 [TBL] [Abstract][Full Text] [Related]
20. Metastatic potential in T1 and T2 colorectal cancer. Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]